| Surgical treatment of symptomatic Rathke cleft cysts: clinical features and results with special attention to recurrence JE Kim, JH Kim, OL Kim, SH Paek, DG Kim, JG Chi, HW Jung Journal of neurosurgery 100 (1), 33-40, 2004 | 252 | 2004 |
| Meningeal hemangiopericytomas: long-term outcome and biological behavior JH Kim, HW Jung, YS Kim, CJ Kim, SK Hwang, SH Paek, DG Kim, ... Surgical neurology 59 (1), 47-53, 2003 | 224 | 2003 |
| Quality of science and reporting of radiomics in oncologic studies: room for improvement according to radiomics quality score and TRIPOD statement JE Park, D Kim, HS Kim, SY Park, JY Kim, SJ Cho, JH Shin, JH Kim European radiology 30, 523-536, 2020 | 223 | 2020 |
| Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma TY Kim, S Zhong, CR Fields, JH Kim, KD Robertson Cancer research 66 (15), 7490-7501, 2006 | 213 | 2006 |
| [18F]3′-deoxy-3′-fluorothymidine PET for the diagnosis and grading of brain tumors SJ Choi, JS Kim, JH Kim, SJ Oh, JG Lee, CJ Kim, YS Ra, JS Yeo, JS Ryu, ... European journal of nuclear medicine and molecular imaging 32, 653-659, 2005 | 212 | 2005 |
| Diffusion radiomics as a diagnostic model for atypical manifestation of primary central nervous system lymphoma: development and multicenter external validation D Kang, JE Park, YH Kim, JH Kim, JY Oh, J Kim, Y Kim, ST Kim, HS Kim Neuro-oncology 20 (9), 1251-1261, 2018 | 124 | 2018 |
| Pre-and posttreatment glioma: comparison of amide proton transfer imaging with MR spectroscopy for biomarkers of tumor proliferation JE Park, HS Kim, KJ Park, SJ Kim, JH Kim, SA Smith Radiology 278 (2), 514-523, 2016 | 121 | 2016 |
| Diffusion-and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma M Kim, SY Jung, JE Park, Y Jo, SY Park, SJ Nam, JH Kim, HS Kim European radiology 30, 2142-2151, 2020 | 118 | 2020 |
| Analysis of the causes of treatment failure in gamma knife radiosurgery for intracranial arteriovenous malformations Y Kwon, SR Jeon, JH Kim, JK Lee, DS Ra, DJ Lee, BD Kwun Journal of neurosurgery 93 (supplement_3), 104-106, 2000 | 111 | 2000 |
| Which combination of MR imaging modalities is best for predicting recurrent glioblastoma? Study of diagnostic accuracy and reproducibility HS Kim, MJ Goh, N Kim, CG Choi, SJ Kim, JH Kim Radiology 273 (3), 831-843, 2014 | 110 | 2014 |
| A systematic review reporting quality of radiomics research in neuro-oncology: toward clinical utility and quality improvement using high-dimensional imaging features JE Park, HS Kim, D Kim, SY Park, JY Kim, SJ Cho, JH Kim BMC cancer 20, 1-11, 2020 | 108 | 2020 |
| Sox17 promotes tumor angiogenesis and destabilizes tumor vessels in mice H Yang, S Lee, S Lee, K Kim, Y Yang, JH Kim, RH Adams, JM Wells, ... The Journal of clinical investigation 123 (1), 2012 | 107 | 2012 |
| Chordomas and chondrosarcomas of the skull base: comparative analysis of clinical results in 30 patients YH Cho, JH Kim, SK Khang, JK Lee, CJ Kim Neurosurgical review 31, 35-43, 2008 | 105 | 2008 |
| A practical scoring system to determine whether to proceed with surgical resection in recurrent glioblastoma CK Park, JH Kim, DH Nam, CY Kim, SB Chung, YH Kim, HJ Seol, TM Kim, ... Neuro-oncology 15 (8), 1096-1101, 2013 | 95 | 2013 |
| A novel weighted scoring system for estimating the risk of rapid growth in untreated intracranial meningiomas EJ Lee, JH Kim, ES Park, YH Kim, JK Lee, SH Hong, YH Cho, CJ Kim Journal of neurosurgery 127 (5), 971-980, 2017 | 84 | 2017 |
| Phase III randomized trial of autologous cytokine-induced killer cell immunotherapy for newly diagnosed glioblastoma in Korea DS Kong, DH Nam, SH Kang, JW Lee, JH Chang, JH Kim, YJ Lim, ... Oncotarget 8 (4), 7003, 2017 | 82 | 2017 |
| Efficacy and safety of cabergoline as first line treatment for invasive giant prolactinoma EH Cho, SA Lee, JY Chung, EH Koh, YH Cho, JH Kim, CJ Kim, MS Kim Journal of Korean medical science 24 (5), 874-878, 2009 | 62 | 2009 |
| Pseudoprogression in patients with glioblastoma: assessment by using volume-weighted voxel-based multiparametric clustering of MR imaging data in an independent test set JE Park, HS Kim, MJ Goh, SJ Kim, JH Kim Radiology 275 (3), 792-802, 2015 | 61 | 2015 |
| Identification of early response to anti-angiogenic therapy in recurrent glioblastoma: amide proton transfer–weighted and perfusion-weighted MRI compared with diffusion … JE Park, HS Kim, SY Park, SC Jung, JH Kim, HY Heo Radiology 295 (2), 397-406, 2020 | 59 | 2020 |
| Efficacy and safety of fractionated stereotactic radiosurgery for large brain metastases WJ Jeong, JH Park, EJ Lee, JH Kim, CJ Kim, YH Cho Journal of Korean Neurosurgical Society 58 (3), 217-224, 2015 | 57 | 2015 |
